TY - JOUR
T1 - 3D printing
T2 - Principles and pharmaceutical applications of selective laser sintering
AU - Awad, Atheer
AU - Fina, Fabrizio
AU - Goyanes, Alvaro
AU - Gaisford, Simon
AU - Basit, Abdul W.
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/8/30
Y1 - 2020/8/30
N2 - Pharmaceutical three-dimensional (3D) printing is a modern fabrication process with the potential to create bespoke drug products of virtually any shape and size from a computer-aided design model. Selective laser sintering (SLS) 3D printing combines the benefits of high printing precision and capability, enabling the manufacture of medicines with unique engineering and functional properties. This article reviews the current state-of-the-art in SLS 3D printing, including the main principles underpinning this technology, and highlights the diverse selection of materials and essential parameters that influence printing. The technical challenges and processing conditions are also considered in the context of their effects on the printed product. Finally, the pharmaceutical applications of SLS 3D printing are covered, providing an emphasis on the advantages the technology offers to drug product manufacturing and personalised medicine.
AB - Pharmaceutical three-dimensional (3D) printing is a modern fabrication process with the potential to create bespoke drug products of virtually any shape and size from a computer-aided design model. Selective laser sintering (SLS) 3D printing combines the benefits of high printing precision and capability, enabling the manufacture of medicines with unique engineering and functional properties. This article reviews the current state-of-the-art in SLS 3D printing, including the main principles underpinning this technology, and highlights the diverse selection of materials and essential parameters that influence printing. The technical challenges and processing conditions are also considered in the context of their effects on the printed product. Finally, the pharmaceutical applications of SLS 3D printing are covered, providing an emphasis on the advantages the technology offers to drug product manufacturing and personalised medicine.
KW - 3D printed drug products
KW - Additive manufacturing
KW - Digital health
KW - Gastrointestinal drug delivery systems
KW - Personalized medicines
KW - Powder bed fusion
KW - Printlets
UR - http://www.scopus.com/inward/record.url?scp=85088021412&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2020.119594
DO - 10.1016/j.ijpharm.2020.119594
M3 - Article
C2 - 32622811
AN - SCOPUS:85088021412
SN - 0378-5173
VL - 586
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
M1 - 119594
ER -